CIL - Thalassemia Bal Sewa Yojana
"A flagship CSR project of Coal India Ltd"
About Thalassemia Bal Sewa Yojana
Thalassemia is an inherited blood disorder that causes a body to have less
hemoglobin than normal. It is a rare burdensome disease requiring lifelong repeated blood transfusion,
as well as other expensive medical interventions for survival. Aplastic Anaemia is a condition that
occurs when body stops producing enough new blood cells.
It is estimated that more than 10,000 Thalassemia children are born every year in India. Similarly, 9400 people are diagnosed with Aplastic Anaemia every year. These diseases pose emotional, psychological and economic burden on the affected families especially those from rural and poor backgrounds besides placing great burden on healthcare services.
Permanent cure of these ailments lies in Stem Cell Transplant also known as Bone Marrow Transplant (BMT). Further, it is found that the treatment is more successful if BMT is done at an early age. Considering the challenges as stated above, Coal India Limited, under the auspices of the Ministry of Health & Family Welfare, Government of India has come up with the unique CSR initiative of supporting the treatment of children affected by these two diseases.
CIL is the first PSU to take up CSR project in 2017, for curative treatment of Thalassemia. Financial assistance upto Rs.10 lakh is provided to eligible patients for Bone Marrow Transplant in ten prominent hospitals spread across the country. From 2021, Aplastic Anaemia patients are also covered under the scheme.